NCT03878407View on ClinicalTrials.gov

Identification of Patients With Age-Related Clonal Hematopoiesis (ARCH) Among Cancer Survivors

Active, not recruitingOBSERVATIONAL

Enrollment

2,400

Participants

Timeline

Start Date

January 18, 2019

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions

Cancer

Interventions

OTHER

Monitoring of ARCH variants

Blood samples will be tested for mutations, before patients are given Standard of Care chemotherapy/radiation or after given Standard of Care chemotherapy/radiation. Another testing is done after 3 months and after 1 year if positive for ARCH.

Trial Locations (1)

M5G 2M9

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors

lead

University Health Network, Toronto

OTHER

NCT03878407 - Identification of Patients With Age-Related Clonal Hematopoiesis (ARCH) Among Cancer Survivors | Biotech Hunter | Biotech Hunter